4 unchanged sentences
The Special Committee’s outside counsel contacted the SEC to inform of the Special Committee’s investigation.
−Removed: Furnish the exhibits required by Item 601 of Regulation S-K (§ 229.601 of this chapter).
Incorporated by Reference
1 unchanged sentence
Amended and Restated Bylaws
−Removed: Olema Pharmaceuticals, Inc.
−Removed: 2022 Inducement Plan
−Removed: Form of Stock Option Agreement and Option Grant Notice under the Inducement Plan.
−Removed: Offer Letter by and between the Registrant and Naseem Zojwalla, dated December 15, 2021.
+Added: Drug Discovery Collaboration and License Agreement by and between the Registrant and Aurigene Discovery Technologies Limited, dated June 7, 2022.
Certification of Chief Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
10 unchanged sentences
Filed herewith.
−Removed: Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
+Added: Portions of this Agreement have been redacted in compliance with Regulation S-K Item 601(b)(10).
+Added: Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Olema Pharmaceuticals, Inc.
+Added: August 9, 2022
/s/ Sean Bohen, M.D., Ph.D.
3 unchanged sentences
Olema Pharmaceuticals, Inc.
+Added: August 9, 2022
/s/ Shane Kovacs
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.